GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Revive Therapeutics Ltd (XCNQ:RVV) » Definitions » Notes Receivable

Revive Therapeutics (XCNQ:RVV) Notes Receivable : C$0.00 Mil (As of Dec. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Revive Therapeutics Notes Receivable?

Revive Therapeutics's Notes Receivable for the quarter that ended in Dec. 2024 was C$0.00 Mil.


Revive Therapeutics Notes Receivable Historical Data

The historical data trend for Revive Therapeutics's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Revive Therapeutics Notes Receivable Chart

Revive Therapeutics Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Notes Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Revive Therapeutics Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Notes Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Revive Therapeutics Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.


Revive Therapeutics Notes Receivable Related Terms

Thank you for viewing the detailed overview of Revive Therapeutics's Notes Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


Revive Therapeutics Business Description

Traded in Other Exchanges
Address
82 Richmond Street East, The Canadian Venture Building, Toronto, ON, CAN, M5C 1P1
Revive Therapeutics Ltd is focused on the research, development, and commercialization of novel psychedelic and cannabinoid-based life sciences products and drug repurposing for infectious diseases. The firm's technology is being developed to fill the medical needs for diseases and disorders such as pain, inflammation, and wound care. Currently, the Company is exploring the use of Bucillamine for the potential treatment of public health medical emergencies and rare inflammatory disorders. Revive is also advancing the development of Psilocybin-based therapeutics through various program.
Executives
Michael Frank Director, Senior Officer
Derrick Alexander Welsh Director or Senior Officer of Insider or Subsidiary (other than in 4,5,6)

Revive Therapeutics Headlines

No Headlines